Results 141 to 150 of about 5,438,163 (262)

A STUDY OF ROLE OF PLATELET COUNT/SPLEEN DIAMETER RATIO AS A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENT WITH CHRONIC LIVER DISEASE

open access: yesNational Journal of Medical Research, 2014
Background: In patients of chronic liver disease, the parameters directly linked to portal hypertension such as splenomegaly and decreased platelet count were predictors of presence of esophageal varices.
Jayesh Sharma   +3 more
doaj  

Dilation in EoE: Still Necessary?

open access: yesInflammatory Intestinal Diseases
Background: Eosinophilic esophagitis (EoE) is a chronic inflammatory immune-mediated disease characterized by eosinophilic esophageal inflammation, leading to remodeling, fibrosis, and stricture formation.
Christoph Schlag
doaj   +1 more source

Epithelial architecture and signaling activity in the adult human esophagus

open access: yesFrontiers in Cell and Developmental Biology
Barrier epithelia function to shield the inside of our bodies from external stressors and pathogens. The esophageal epithelium is no exception, providing protection while at the same time transporting food to the stomach. Although many epithelial tissues
David Grommisch   +3 more
doaj   +1 more source

Survival rate of gastric and esophageal cancers in Ardabil Province, North-West of Iran [PDF]

open access: yes
Background: Upper gastrointestinal cancer is the most common cancer in Ardabil Province, North-West of Iran, accounting for more than 50% of all cancer deaths in this area.
درخشان, محمدحسین   +10 more
core  

Gut Health in Ostriches (Struthio camelus): Insights Into Intestinal Structure, Functions, Microbiome, and Improvement Strategies

open access: yesAnimal Research and One Health, EarlyView.
Our paper systematically reviews the intestinal structure, function, and microbiota of ostriches, along with strategies for improving their gut health. We analyze how these factors collectively influence intestinal homeostasis and ostrich welfare, emphasizing probiotics as a promising intervention to enhance gut health, boost population well‐being, and
Zi‐Qun Zhang   +6 more
wiley   +1 more source

How the use of esophageal PH monitoring in investigating gastroesophageal reflux disease has changed r a 18-year experience in a pediatric department.

open access: yes, 2008
Use of esophageal PH monitoring in investigating gastroesophageal reflux disease has changed r a 18-year experience in a pediatric ...
22) M. Fornaro   +4 more
core   +1 more source

Gastro-esophageal reflux disease and the lung transplant recipient.

open access: yes, 2013
Gastro-esophageal reflux disease and the lung transplant ...
Beatrice Aramini
core  

Combined Modality Therapy of Esophageal Cancer

open access: yes, 2008
Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management ...
Arlene Forastiere, Rosalyn A. Juergens
core   +1 more source

Clock Genes Regulate Ca2+ Signaling and Mitochondrial Bioenergetics to Inhibit Sjögren Disease

open access: yesArthritis &Rheumatology, EarlyView.
Objective Although Ca2+ signaling and metabolism have been identified as key determinants for the development of Sjögren disease (SjD), the intricate connection between them and salivary gland physiology remains poorly understood. Methods Fluorescence‐based Ca2+ imaging, RNA sequencing, and mitochondrial activity were used to investigate the effects of
Viktor R. Drel   +12 more
wiley   +1 more source

Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The purpose of this study was to assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients aged 2 to 17 years with ...
Hermine I. Brunner   +52 more
wiley   +1 more source

Home - About - Disclaimer - Privacy